Issue Date: July 13, 2009
EC To Intensify Pharma Scrutiny
The European Commission says it will intensify its scrutiny of anticompetitive practices in the pharmaceutical industry, particularly practices that hinder the introduction of low-cost generic drugs. An inquiry launched by the administrative arm of the European Union more than a year ago (C&EN Online Latest News, Jan. 17, 2008) turned up significant delays in the introduction of generics after original makers' patents expired. Neelie Kroes, commissioner for competition policy, says that the first . . .
To view the rest of this content, please log in with your ACS ID.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society